Dec. 27, 2023
by Andrii Buvailo
Biopharma insight
The biopharma industry experienced a challenging year in 2023, marked by a significant decrease in funding and a high number …
Dec. 26, 2023
by Andrii Buvailo
Biopharma insight
In the current climate of global economic uncertainty, one area of pharmaceutical development is bucking the trend with a significant …
Dec. 20, 2023
by Dr. Khalid Fakhro
Biopharma insight
Precision medicine is fast developing, with genomics being a particularly promising field. As genomic medicine advances, we get steadily closer …
Nov. 27, 2023
by Andrii Buvailo
Biopharma insight
In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire …
Nov. 17, 2023
by Andrii Buvailo
Biopharma insight
Companies are increasingly turning to generative artificial intelligence (AI) to develop new therapeutics, giving biotech companies with patents on these …
Nov. 7, 2023
by Bohdana Sokolova
Biopharma insight
In the ongoing pursuit of new drugs and medical treatments, the pharmaceutical sector faces a complex task: verifying the safety …
Nov. 7, 2023
by Tim Sandle
Biopharma insight
The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data …
Nov. 3, 2018
by Andrii Buvailo
Biopharma insight
The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked …
Oct. 20, 2023
by Andrii Buvailo
Biopharma insight
It is hard to overestimate the potential of biotechnology to address some of the most pressing challenges of the 21st …
Oct. 20, 2023
by Andrii Buvailo
Biopharma insight
‘Garbage in, garbage out’ is a well-known principle in the machine learning (ML) community, and it is certainly true when …
Oct. 6, 2023
by Andrii Buvailo
Biopharma insight
From gene editing and artificial intelligence (AI)-driven protein design, to cutting-edge 3D bioprinting, tissue engineering and microfluidics – Lithuania appears …
Aug. 16, 2023
by Anthony Platt
Biopharma insight
The UK’s health technology market has seen unprecedented levels of M&A transactions and fundraising. The Covid-19 pandemic acted as a …